Showing results (611-620 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Information tools for exploratory data analysis in population pharmacokineticsO Petricoul, L Claret, D Barbolosi, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2018
Modeling near-continuous clinical endpoint as categorical: application to longitudinal exposure-response modeling of Mayo scores for golimumab in patients with ulcerative colitisChuanpu Hu, Omoniyi J Adedokun, Liping Zhang, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 29, 2016
Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenzaAmber M SmithJournal of Pharmacokinetics and Pharmacodynamics|March 22, 2014
Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexateKayode Ogungbenro, Leon Aarons, Journal of Pharmacokinetics and Pharmacodynamics|March 13, 2014
Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deploymentJohn M Harrold, Anson K AbrahamJournal of Pharmacokinetics and Pharmacodynamics|February 15, 2017
Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrationsJim H Hughes, Richard N Upton, David J R FosterJournal of Pharmacokinetics and Pharmacodynamics|January 12, 2017
Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulationsGilbert Koch, William J Jusko, Johannes SchroppJournal of Pharmacokinetics and Pharmacodynamics|April 8, 2017
The effect of using a robust optimality criterion in model based adaptive optimizationEric A Strömberg, Andrew C HookerJournal of Pharmacokinetics and Pharmacodynamics|June 14, 2008
Onset dynamics of type A botulinum neurotoxin-induced paralysisFrank J Lebeda, Michael Adler, Keith Erickson, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 10, 2019
Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotesCarrie German, Minu Pilvankar, Andrzej PrzekwasPageof 107